Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Astellas
Astellas
ESMO: Seagen's Padcev pulls its weight in combo with Merck's Keytruda
Fierce Pharma
Thu, 09/8/22 - 04:40 pm
Merck
Keytruda
Astellas
Seagen
Padcev
ESMO
urothelial cancer
Astellas reports Phase III data of fezolinetant for menopause-linked VMS
Clinical Trials Arena
Tue, 09/6/22 - 10:50 am
Astellas
clinical trials
menopause
China
fezolinetant
vasomotor symptoms
hot flashes
Revealed: which pharma companies leading the way in artificial intelligence
Clinical Trials Arena
Fri, 08/26/22 - 10:37 am
artificial intelligence
Pfizer
Novartis
AstraZeneca
Johnson & Johnson
Bristol Myers Squibb
Takeda
GSK
Bayer
Astellas
Astellas' menopause therapy accepted for FDA review 5 months after late-phase study mars record
Fierce Biotech
Thu, 08/18/22 - 12:40 pm
Astellas
menopause
FDA
clinical trials
Asia
fezolinetant
hot flashes
July Brings Layoffs, Job Creation for the Life Sciences
BioSpace
Wed, 08/3/22 - 09:32 pm
layoffs
hirings
Astellas
Pfizer
Eikon Therapeutics
Bayer
Avadel Pharma
Heron Therapeutics
Adverum Biotechnologies
Biogen
Eisai
X4 Pharmaceuticals
Assembly Biosciences
Astellas Pharma Plans to Open New Biotech Facility in California
Xtalks
Fri, 07/29/22 - 09:56 am
Astellas
R&D
California
San Francisco
Seagen, Astellas claim positive results in study key to cancer drug's success
BioPharma Dive
Tue, 07/26/22 - 11:26 am
Seagen
Astellas
Padcev
Merck
Keytruda
bladder cancer
clinical trials
Astellas to Open New Biotech Campus in South San Francisco
Contract Pharma
Fri, 07/22/22 - 10:16 am
Astellas
San Francisco
biotech
California
Mogrify, Astellas Pharma partner for sensorineural hearing loss treatment
Pharmaceutical Business Review
Tue, 07/5/22 - 11:08 am
Mogrify
Astellas
regenerative medicine
hearing loss
Astellas pumps $90m into Sutro immuno-oncology alliance
Pharmaforum
Tue, 06/28/22 - 10:35 am
Astellas
Sutro BioPharma
antibody-drug conjugate
cancer
immuno-oncology
FDA Presses Pause on Astellas' Pompe Disease Therapeutic
BioSpace
Mon, 06/27/22 - 10:07 am
Astellas
Pompe disease
clinical trials
FDA
AT845
Astellas, despite recent setbacks, opens $100M gene therapy plant
BioPharma Dive
Wed, 06/8/22 - 11:05 pm
Astellas
gene therapy
drug manufacturing
North Carolina
GO! Astellas picks up partner in convertibleCAR for backloaded $780M antibody project
Fierce Biotech
Wed, 06/1/22 - 09:53 am
Astellas
immuno-oncology
R&D
Go Therapeutics
glycoprotein targets
After high-profile US rejection for roxadustat, Astellas touts its safety in new pooled analysis
Fierce Pharma
Thu, 05/19/22 - 10:32 am
Astellas
roxadustat
FibroGen
ERA
erythropoietin
Astellas, Twist Join Forces to Enhance Tumor Immunity
BioSpace
Tue, 05/10/22 - 10:38 pm
Astellas
Twist Bioscience
R&D
antibodies
tumor immunity
Astellas, Tmunity, Underscore Rocky Terrain of CAR-T and Gene Therapies
BioSpace
Mon, 04/25/22 - 10:38 pm
Astellas
Tmunity
CAR-T
gene therapy
myotubular myopathy
Astellas takes $170m charge as it drops DMD gene therapies
Pharmaforum
Fri, 04/22/22 - 10:48 am
Astellas
gene therapy
Duchenne Muscular Dystrophy
earnings
AACR 2022 – A weekend of updates yields few winners
EP Vantage
Tue, 04/12/22 - 10:34 am
AACR
Bicycle Therapeutics
Rubius Therapeutics
C4 Therapeutics
Zentalis
Affimed
Seagen
Astellas
Astellas' menopause drug suffers rare setback as failed Asian trial blots previously pristine record
Fierce Biotech
Tue, 03/15/22 - 10:41 am
Astellas
menopause
hot flashes
clinical trials
fezolinetant
Astellas’ eyes filings for menopause drug fezolinetant after ph3 win
Pharmaforum
Mon, 03/7/22 - 10:07 am
Astellas
menopause
clinical trials
fezolinetant
hot flashes
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »